Several aspects of normal aging and dementia of various types, emphasizing Alzheimer's disease, are to be investigated in this Program Project. P. Fuld is in charge of a psychometric analysis of a large group of in- and out-patients, many of whom ultimately come to autopsy. She also does psychometric assays on patients in L. Thal's treatment trials. The latter involve the cholinomimetic drugs physostigmine and tetrahydroaminoacridine. With the former, preliminary results are strongly positive and correlate with the degree of choline esterase inhibition in CSF. E. Buschke does psychologic studies on memory processing and retraining. R. Terry will do extensive neuropathologic studies on autopsy specimens entering the study so that appropriately evaluated tissue can be distributed to the collaborating investigators. He will also count neocortical and subcortical neurons and glia as well as plaques and tangles in various types of dementia, and will, by immunocytochemical techniques, map neuropeptides, somatostatin, substance P, vasopressin, and choline acetyltransferase in CNS. P. Davies will do 16 assays on neurotransmitters, their metabolic products and related enzymes (relevant to acetylcholine, four peptides, GABA, dopamine, norepinephrine, and serotonin) on tissue from multiple sites of human CNS specimens, and will be studying the control of somatostatin release in relation to cholinergic agents in neuroblastoma cells in culture. S.-H. Yen will examine the biochemical properties of proteins and their cross-linkages making up neurofibrillary tangles. J. Goldman will examine contractile proteins in the aging CNS, since they are involved in the Hirano body and might also have to do with determining shape and extent of neurites. Analyses involve psychometrics, light and electron microscopy, computerized image analysis morphometry, immunocytochemistry, enzyme assays, radio-immuno-assay and high pressure liquid chromatography. Normal aging rats, cell cultures, and autopsied human brain tissue are utilized. Mice and rabbits are used in preparing antisera.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG005386-03
Application #
3090983
Study Section
(SSS)
Project Start
1984-08-01
Project End
1988-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Shimohama, S; Saitoh, T; Gage, F H (1990) Differential expression of protein kinase C isozymes in rat cerebellum. J Chem Neuroanat 3:367-75
Iimoto, D S; Masliah, E; DeTeresa, R et al. (1990) Aberrant casein kinase II in Alzheimer's disease. Brain Res 507:273-80
Love, S; Burrola, P; Terry, R D et al. (1989) Immunoelectron microscopy of Alzheimer and Pick brain tissue labelled with the monoclonal antibody Alz-50. Neuropathol Appl Neurobiol 15:223-31
Armstrong, D M; Benzing, W C; Evans, J et al. (1989) Substance P and somatostatin coexist within neuritic plaques: implications for the pathogenesis of Alzheimer's disease. Neuroscience 31:663-71
Cole, G M; Huynh, T V; Saitoh, T (1989) Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells. Neurochem Res 14:933-9
Van Huynh, T; Cole, G; Katzman, R et al. (1989) Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts. Arch Neurol 46:1195-9
Mandel, R J; Gage, F H; Thal, L J (1989) Enhanced detection of nucleus basalis magnocellularis lesion-induced spatial learning deficit in rats by modification of training regimen. Behav Brain Res 31:221-9
Thal, L J; Masur, D M; Blau, A D et al. (1989) Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease. J Am Geriatr Soc 37:42-8
Saitoh, T; Iimoto, D (1989) Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease. Prog Clin Biol Res 317:769-80
Ueda, K; Cole, G; Sundsmo, M et al. (1989) Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid beta-protein precursor involved? Ann Neurol 25:246-51

Showing the most recent 10 out of 39 publications